Table 2.
Temperature (°C) | Time (min) | Harmane | Norharmane | MeIQx | 4,8-DiMeIQx | PhIP | Total HCA | |
---|---|---|---|---|---|---|---|---|
Inside | 150 | 5 | 0.59 | 0.26 | <0.08 | <0.08 | <0.08 | 0.85 |
10 | 1.34 | 0.37 | <0.08 | <0.08 | <0.08 | 1.72 | ||
15 | 1.75 | 0.50 | <0.08 | <0.08 | <0.08 | 2.25 | ||
190 | 5 | 0.84 | 0.60 | <0.08 | 0.32 | <0.08 | 1.75 | |
10 | 1.32 | 0.79 | <0.08 | 0.38 | <0.08 | 2.49 | ||
15 | 1.99 | 0.86 | <0.08 | 0.45 | 0.57 | 3.87 | ||
230 | 5 | 2.40 | 1.37 | 0.73 | 0.56 | 1.48 | 6.54 | |
10 | 3.38 | 1.76 | 0.58 | 0.80 | 5.36 | 11.89 | ||
15 | 7.75 | 1.87 | 1.26 | 2.24 | 19.46 | 32.58 | ||
Surface | 150 | 5 | 1.56 | 0.33 | <0.08 | 0.36 | <0.08 | 2.24 |
10 | 1.60 | 0.50 | <0.08 | 0.41 | 0.52 | 3.03 | ||
15 | 2.42 | 0.70 | 1.41 | 0.79 | 0.58 | 5.89 | ||
190 | 5 | 2.94 | 1.40 | 1.50 | 0.76 | 3.03 | 9.64 | |
10 | 9.50 | 2.91 | 3.23 | 2.27 | 11.31 | 29.22 | ||
15 | 10.18 | 5.80 | 3.65 | 3.39 | 17.48 | 40.50 | ||
230 | 5 | 45.01 | 8.01 | 8.70 | 13.74 | 232.87 | 308.34 | |
10 | 49.93 | 12.54 | 10.14 | 15.79 | 254.42 | 342.81 | ||
15 | 107.00 | 33.02 | 27.04 | 59.19 | 449.60 | 675.86 |
MeIQx: 3,8-dimethyl-imidazo(4,5-f)quinoxaline; 4,8-DiMeIQx: 2-amino-3,4,8-trimethyl-imidazo (4,5-f)quinoxaline; PhIP: 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine.